期刊
ADVANCED DRUG DELIVERY REVIEWS
卷 61, 期 14, 页码 1316-1323出版社
ELSEVIER
DOI: 10.1016/j.addr.2009.07.016
关键词
Neuroprotection; Alzheimer's disease; Amyotrophic lateral sclerosis; Huntington's disease; Parkinson's disease; Therapeutics
资金
- NIH [P30 AG13846, NS52724]
- KOSEF [800-20080848]
Mitochondria are the power engine generating biochemical energy in the cell. Mitochondrial dysfunction and bioenergy deficiency is closely linked to the pathogenesis of neurodegenerative disorders. Mitochondria play a variety of roles by integrating extracellular signals and executing important intracellular events in neuronal survival and death. in this context, the regulation of mitochondrial function via therapeutic approaches may exert some salutary and neuroprotective mechanisms. Understanding the relationship of mitochondria-dependent pathogenesis may provide important pharmacological utility in the treatment of neurodegenerative conditions such as Alzheimer's disease, amyotrophic lateral sclerosis, Huntington's disease and Parkinson's disease. Indeed, the modulation of mitochondrial pathways is rapidly emerging as a novel therapeutic target. This review focuses on how mitochondria are involved in neurodegeneration and what therapeutics are available to target mitochondrial pathways. (C) 2009 Elsevier B.V. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据